An international perspective on pediatric psychopharmacology

International Review of Psychiatry

Volumn 20, Issue 2, 2008, Pages 121-126

  Vitiello, Benedetto ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADOLESCENT; ATTITUDE TO MENTAL ILLNESS; BEHAVIOR DISORDER; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; CULTURAL FACTOR; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; EMOTIONAL DISORDER; FUNDING; HEALTH CARE SYSTEM; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISEASE; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPHARMACOLOGY; RESOURCE ALLOCATION; REVIEW; SUICIDAL IDEATION; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ASIA; ATTITUDE; CULTURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG AND NARCOTIC CONTROL; EUROPE; HEALTH SERVICES ADMINISTRATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL COOPERATION; MARKETING; MENTAL DISORDERS; PEDIATRICS; PRESCRIPTIONS, DRUG; PSYCHOPHARMACOLOGY; UNITED STATES; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 41749094975     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260801887710     Document Type: Review

References (43)

1. American Academy of Child and Adolescent Psychiatry (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 894-921.
2. American Academy of Pediatrics (2001). Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics, 108, 1033-1044.
3. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. Washington, DC: American Psychiatric Association.
4. Bijl, R. V., de Graf, R., & Hiripi, E. (2003). The prevalence of treated and untreated mental disorders in five countries. Health Affairs, 22, 122-1333.
5. Buitelaar, J. K., Barton, J., Danckaerts, M., Friedrichs, E., Gillberg, C., Hazell, P. L., et al. (2006). A comparison of North American versus non-North American ADHD study populations. European Child and Adolescent Psychiatry, 15, 177-181.
6. Canino, G., Shrout, P. E., Rubio-Stipec, M., Bird, H. R., Bravo, M., Ramirez, R., et al. (2004). The DSM-IV rates of child and adolescent disorders in Puerto Rico: Prevalence, correlates, service use, and the effects of impairment. Archives of General Psychiatry, 61, 85-93.
7. Costello, E. J., Mustillo, S., Erkanli, A, Keeler, G., & Angold, A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60, 837-844.
8. Cox, E. R., Motheral, B. R., Henderson, R. R., & Mager, D. (2003). Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: Results from a commercially insured US sample. Pediatrics, 111, 237-243.
9. Duffy, A. (2007). Does bipolar disorder exist in children? A selected review. Canadian Journal of Psychiatry, 52, 409-417.
10. Faraone, S. V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry, 2, 104-113.
11. Fegert, J. M., Kolch, M., Zito, J. M., Glaeske, G., & Janhsen, K. (2006). Antidepressant use in children and adolescents in Germany. Journal of Child and Adolescent Psychopharmacology, 16, 197-206.
12. Fombonne, E. (2003). The prevalence of autism. Journal of the American Medical Association, 289, 87-89.
13. Food and Drug Administration. 2007. FDA approved Risperdal for two psychiatric conditions in children and adolescents. Available at Website: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01686.html (Accessed on October 29, 2007).
14. Jensen, P. S., Mrazek, D., Knapp, P. K., Steinberg, L., Pfeffer, C., Schowalter, & Shapiro, T. (1997). Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1672-1679.
15. Kessler, R. C., Frank, R. G., Edlund, M., Katz, S. J., Lin, E., & Leaf, P. (1997). Differences in the use of psychiatric outpatient services between the United States and Ontario. New England Journal of Medicine, 336, 551-557.
16. Kolch, M., Schnoor, K., & Fegert, J. M. (2007). The EU-regulation on medicinal products for paediatric use: Impacts on child and adolescent psychiatry and clinical research with minors. European Child and Adolescent Psychiatry, 16, 229-235.
17. Kratochvil, C. J., Vitiello, B., Walkup, J., Emslie, G., Waslick, B. D., Weller, E. B., et al. (2006). SSRIs in pediatric depression: Is the balance between benefits and risks favorable? Journal of Child and Adolescent Psychopharmacology, 16, 11-24.
18. Kutcher, S., Aman, M., Brooks, S. J., Buitelaar, J., van Daalen, E., Fegert, J., et al. (2004). International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Neuropsychopharmacology, 14, 11-28.
19. Lambert, K. G. (2005). Rising rates of depression in today's society: Consideration of the roles of effort-based rewards and enhanced resilience in day-to-day functioning. Neuroscience and Biobehavioral Reviews, 30, 497-510.
20. Malhotra, S., Kohli, A., & Arun, P. (2002). Prevalence of psychiatric disorders in school children in Chandigarh, India. Indian Journal of Medical Research, 116, 21-28.
21. Matsuura, M., Okubo, Y., Kojima, T., Takahashi, R., Wang, Y. F., Shen, Y. C., et al. (1993). A cross-national prevalence study of children with emotional and behavioral problems - A WHO collaborative study in the Western Pacific Region. Journal of Child Psychology and Psychiatry, 34, 307-315.
22. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64, 1032-1039.
23. National Institute for Clinical Excellence (2006). Methylphenidate, atomoxetine and dexamfetamine for attention-deficit hyperactivity disorder (ADHD) in children and adolescents. Technology Appraisal Guidance No. 98. London, UK: National Institute for Health and Clinical Excellence (NICE).
24. Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63, 679-685.
25. Parker, G., Gladstone, G., & Chee, K. T. (2001). Depression in the planet's largest ethnic group: The Chinese. American Journal of Psychiatry, 158, 857-864.
26. Polanczyk, G., Silva de Lima, M., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The wordwide prevalence of ADHD: A systematic review and metaregressino analysis. American Journal of Psychiatry, 164, 942-948.
27. Roberts, R. E., Attkinson, C. C., & Rosenblatt, A. (1998). Prevalence of psychopathology among children and adolescents. American Journal of Psychiatry, 155, 715-725.
28. Santosh, P. J., Taylor, E., Swanson, J., Wigal, T., Chuang, S., Davies, M., et al. (2005). Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clinical Neuroscience Research, 5, 307-314.
29. Scheffler, R. M., Hinshaw, S. P., Modrek, S., & Levine, P. (2007). The global market for ADHD medications. Health Affairs, 26, 450-457.
30. Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., et al. (2004). European clinical guidelines for hyperkinetic disorder - first upgrade. European Child Adolescent Psychiatry, 13, 17-30.
31. Timimi, S., & Taylor, E. (2004). ADHD is best understood as a cultural factor. British Journal of Psychiatry, 184, 8-9.
32. US Congress (1997). Food and Drug Administration Modernization Act. Public Law No. 105-115.
33. US Congress (2002). Best Pharmaceuticals for Children Act (BPCA). Public Law No. 107-109.
34. US Congress (2003). Pediatric Research Equity Act of 2003. Public Law No. 108-155.
35. Verhulst, F. C., van der Ende, J., Ferdinand, R. F., & Kasius, M. C. (1997). The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Archives of General Psychiatry, 54, 329-336.
36. Vitiello, B., Zuvekas, S., & Norquist, D. G. (2006). National estimates of antidepressant medication use among US children in 1997-2002. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 271-279.
37. Vitiello, B., Heiligenstein, J. J., Riddle, M. A., Greenhill, L. L., & Fegert, J. M. (2004). The interface between publicly funded and industry-funded research in pediatric psychopharmacology: Opportunities for integration and collaboration. Biological Psychiatry, 56, 3-9.
38. Williams, J., & Taylor, E. (2006). The evolution of hyperactivity, impulsivity and cognitive diversity. Journal of the Royal Society Interface, 3, 399-413.
39. World Health Organization (WHO) (1993). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: WHO.
40. WHO (2002). Suicide rates and absolute numbers of suicide by country (2002). Available at: http://www.who.int/mental_health/prevention/suicide (Accessed October 23, 2007).
41. WHO World Health Organization Mental Health Survey Consortium (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of the American Medical Association, 291, 2581-2590.
42. Zito, J. M., Tobi, H., de Jong-van den Berg, L. T. W., Fegert, J. M., Safer, D. J., Janhsen, K., et al. (2006). Antidepressant prevalence for youths: A multi-national comparison. Pharmacoepidemiology and Drug Safety, 15, 793-798.
43. Zuvekas, S. H., Vitiello, B., & Norquist, N. S. (2006). Recent Trends in Stimulant Medication Use among US Children. American Journal of Psychiatry, 163, 579-585.